Biogerontology Research Foundation CSO Outlines Plans for Clinical Trials for Using Geroprotectors to Prevent and Treat COVID-19

APRIL 7, 2020

Biogerontology Research Foundation CSO Outlines Plans for Clinical Trials for Using Geroprotectors to Prevent and Treat COVID-19

Tuesday, April 07, 2020, London, UK: Alex Zhavoronkov, Chief Scientific Officer of the Biogerontology Research Foundation, outlines major conclusions and key points from his recent scientific article on clinical trials to rapidly validate the use of geroprotectors (such as metformin, rapamycin and others) to prevent and treat COVID-19 in the elderly, in a recent press release by the scientific journal Aging.

Press enquiries

All enquiries should be

directed to

info@bg-rf.org.uk